Patents by Inventor Victoria Jackson

Victoria Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PICOLINAMIDE DERIVATIVES USEFUL AS AGRICULTURAL FUNGICIDES
    Publication number: 20220256855
    Abstract: The present invention relates to picolinic acid derivatives that are useful in treating fungal diseases, particularly in plants.
    Type: Application
    Filed: July 23, 2020
    Publication date: August 18, 2022
    Inventors: Calum MUIR, Ryan BURGIN, Linda JORDAN, Victoria JACKSON
  • PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)-PYRROLIDIN-2-YL]IMIDAZO[1,5-a]-PYRAZIN-1-YL}N-(PYRIDIN-2-YL)-BENZAMIDE
    Publication number: 20220127270
    Abstract: The present disclosure relates, in general, to improved processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)-benzamide, particularly large-scale processes for manufacturing 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide and intermediates used in such processes.
    Type: Application
    Filed: August 28, 2019
    Publication date: April 28, 2022
    Inventors: Paul Allen BETHEL, Lai Chun CHAN, Katie Grace COOPER, Robert John COX, Michael David GOLDEN, Shaun Alan HUGHES, Lucinda Victoria JACKSON, Kirsty Jane MILLARD, Andrew John PHILLIPS, Alexander James TELFORD, Jerry EVARTS, Michael Joseph LAWLER, Remy E. J. N. LITJENS, Peter Johannes Servaas Savio VAN EIJK, Mathilda Maria Henrica VERSTAPPEN, Frank L. M. VOS, Eric Jurriën ZIJP, Qiu JUNYING, Rustam Ferdinand GARREY, David Allen SHORT, Angang WANG
  • PHARMACEUTICAL PROCESS AND INTERMEDIATES
    Publication number: 20220056027
    Abstract: The present disclosure concerns the large-scale manufacture of pharmaceutical compounds, and novel intermediates for use in the manufacture. International Patent Application WO2011154737 discloses morpholine pyrimidines useful for treating cancer, processes for their preparation and pharmaceutical compositions thereof. In particular, WO2011154737 discloses, as experimental Example 2.02 on page 60, the compound 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)—S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b]pyridine (hereafter referred to as the compound of Formula (I)). The structure of the compound of Formula (I) is shown below. A synthetic route to the compound of Formula (I) is described at pages 51 to 57, 66 and 67 of WO2011154737, and is summarised below in Scheme 1.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 24, 2022
    Inventors: Mark Andrew Graham, Lucinda Victoria Jackson, Gary Michael Noonan, Phillip Anthony INGLESBY, David Pranay DAVE, Katie Grace COOPER
  • Kinase inhibitor prodrug for the treatment of cancer
    Patent number: 10507210
    Abstract: Compositions containing and methods of administering TH-4000 are useful in treatment of cancer alone or in combination with other anti-cancer agents.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: December 17, 2019
    Assignee: Auckland UniServices Limited
    Inventors: Adam Vorn Patterson, Jeffrey Bruce Smaill, Shevan Silva, Christopher Paul Guise, Matthew Roy Bull, Victoria Jackson, Tillman Pearce, Nipun Davar
  • KINASE INHIBITOR PRODRUG FOR THE TREATMENT OF CANCER
    Publication number: 20170360790
    Abstract: Compositions containing and methods of administering TH-4000 are useful in treatment of cancer alone or in combination with other anti-cancer agents.
    Type: Application
    Filed: December 3, 2015
    Publication date: December 21, 2017
    Applicants: Auckland UniServices Limited, Threshold Pharmaceuticals, Inc.
    Inventors: Adam Vorn Patterson, Jeffrey Bruce Smaill, Shevan Silva, Christopher Paul Guise, Matthew Roy Bull, Victoria Jackson, Tillman Pearce, Nipun Davar